In today’s excellent blog by Michele Cagan at HSI Baltimore, among the many interesting stories posted is the good news that the FDA is sticking to their guns in denying Merck’s request (again) to allow over the counter sales of Mevacor, a powerful statin drug.
Jenny Thompson puts the Merck request in it’s proper perspective,
“…. [...]
























